全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量
63

相关文章

更多...
-  2019 

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma

DOI: 10.1159/000496018

Keywords: Pancreatic adenocarcinoma, KRAS, BRAF, RET, Targeted therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Pancreatic adenocarcinoma (PDAC) has a grim prognosis. Molecular and genomic analyses revealed that the striking majority of these tumors are driven by KRAS mutation, currently not amenable to targeted therapy. However, other driver mutations were found in a small fraction of patients. Herein we report of 3 cases of patients with metastatic PDAC and wildtype KRAS, found to harbor BRAF or RET pathogenic alterations. The patients were treated with targeted therapies with variable success. In our opinion, those proof-of-concept cases argue in favor of additional research and clinical trials' effort in this small but significant PDAC population with uncommon driver mutations

Full-Text

  
  
  

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133